COMPASS Pathways
CMPS | NASDAQ
$15.01
$0 (0.00%)
Sep 22, 2026, 10:36 AM ET · Market open
Company Profile
COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy. This therapy has advanced through Phase IIb clinical trials for treatment-resistant depression and is currently undergoing Phase II trials for post-traumatic stress disorder. The company previously operated under the name COMPASS Rx Limited before rebranding to COMPASS Pathways plc in August 2020.
Key Executives
| Name | Position |
|---|---|
| Kabir Nath | Chief Executive Officer & Director |
| Teri Loxam | Chief Financial Officer |
| Benjamin Harber | Company Secretary |
| Guy Goodwin | Chief Medical Officer |
| Lars Christian Wilde | Senior Advisor |
| Lori Englebert | Chief Commercial Officer |
| Michael Gold | Chief Research & Development Officer |
| Stephen D. Schultz | Senior Vice President of Investor Relations |
| Steve Levine | Chief Patient Officer |
| Susan C. Stansfield | Advisor |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 05, 2026 | 4 | Filing |
| Aug 05, 2026 | S-3ASR | Automatic shelf registration statement of securiti... |
| Aug 05, 2026 | 8-K | Current Report |
| Aug 05, 2026 | 10-Q | Quarterly Report |
| Jul 07, 2026 | 8-K | Current Report |
| May 29, 2026 | 4 | Filing |
| May 29, 2026 | 4 | Filing |
| May 29, 2026 | 4 | Filing |
| May 29, 2026 | 4 | Filing |
| May 29, 2026 | 4 | Filing |
COMPASS Pathways
| Country | United Kingdom |
| IPO Date | Sep 17, 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 156 |
| CEO | Kabir Kumar Nath |
Contact Details
33 Broadwick Street London,
CH W1F 0DQ United Kingdom
Stock Details
| Ticker Symbol | CMPS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001816590 |
| CUSIP Number | 20451W101 |
| ISIN Number | US20451W1018 |
| SIC Code | 2834 |
Recent News
- 4 days ago / seekingalpha.comCOMPASS Pathways plc (CMPS) Presents at Deutsche Bank 2026 Healthcare Summit Transcript
- 6 days ago / seekingalpha.comCOMPASS Pathways plc (CMPS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- 2 months ago / seekingalpha.comCOMPASS Pathways plc (CMPS) Q2 2026 Earnings Call Transcript
- 2 months ago / defenseworld.netCompass Pathways (CMPS) to Post Quarterly Earnings on Thursday
- 3 months ago / seekingalpha.comCOMPASS Pathways plc (CMPS) Discusses Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile in Depression Transcript
Add to Watchlist
Select watchlists to add or remove CMPS